Dapharco successfully organized the Annual General Meeting 2017
The chairperson operates the Annual General Meeting 2017
Annual General Meeting of Shareholders 2017 Danang Pharmaceutical- Medical Equipment Joint Stock Company was held on April 22nd, 2017 at Danang Trade Union Hotel. Attending the meeting were 667 shareholders and shareholders’ representatives, representing 8,793,896 shares, accounting for 92.53% of the total shares with voting rights at the meeting.
Mr. Tong Viet Phai – Vice Chairman of the Board – General Director of the Company presented the report of the Board of Management, financial statements audited 2016, business results in 2016 with a total revenue of 1,802 billion Vietnamese dongs reaching 100,1% of the plan, profit before tax reached 21.4 billion, exceeding 6.7% compared to the plan. Existing equity is 103.4 billion Vietnamese dongs, increase 3.6% compared to 2015 and business plan in 2017 with the target of the total revenue of 1,850 billion Vietnamese dongs, pre-tax profit is 22 billion Vietnamese Dongs.
Mr. Dang Van Nam – Chairman of the Board – reported to the Meeting for the profit distribution & provision of funds for 2016, implementation of remuneration payment to the Board of Directors and the Supervisory Board in 2016, the activities of the Board of Directors in 2016 on enterprises and supervision activities management, coordination with the Supervisory Board, evaluation of the Board of Directors on the activities of the Executive Board. Orientation for activities and set out basic solutions to achieve the 2017 plan, expected to pay dividends in 2017 which is the remaining 12% of the Investment and Development fund and additional business capital of the company.
Mr. Tong Viet Phai – General Director of Dapharco – reports at the Meeting
The company shares are trading on UPCoM stock exchange- according to plan, the company will switch to register for listing on Hanoi Stock Exchange (HNX) when it is eligible.
The Meeting also approved the operation report of the Supervisory Board, recommendations and proposals to enhance the effectiveness of the Company’s activities in 2017.
The opinions of analyzing business results, discussions and questions of shareholders were satisfactorily explained by the Chairman at the meeting. The content of the reports and operational plans for the coming time of the Board of Management was highly consensus of all shareholders attending the meeting.